|
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
|
National Institutes of Health |
June 15, 2027
|
— |
Nonprofits
|
|
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
|
National Institutes of Health |
June 15, 2027
|
— |
Nonprofits
|
|
Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
|
National Institutes of Health |
June 17, 2027
|
— |
Nonprofits
|
|
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
July 2, 2027
|
— |
Nonprofits
|
|
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
|
National Institutes of Health |
July 12, 2027
|
— |
Nonprofits
|
|
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
|
National Institutes of Health |
July 12, 2027
|
— |
Nonprofits
|
|
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
|
National Institutes of Health |
July 12, 2027
|
— |
Nonprofits
|
|
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
|
National Institutes of Health |
July 17, 2027
|
— |
Nonprofits
|
|
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
|
National Institutes of Health |
August 11, 2027
|
$150k |
Nonprofits
|
|
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
August 18, 2027
|
— |
Nonprofits
|
|
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 7, 2027
|
— |
Nonprofits
|
|
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
|
National Institutes of Health |
September 7, 2027
|
— |
Nonprofits
|
|
Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 7, 2027
|
— |
Nonprofits
|
|
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 7, 2027
|
— |
Nonprofits
|
|
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
|
National Institutes of Health |
September 7, 2027
|
— |
Nonprofits
|
|
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 10, 2027
|
— |
Nonprofits
|
|
Department of Defense HIV/AIDS Prevention Program
|
Defense Health Agency Contracting Activity - DHACA |
September 18, 2027
|
— |
Nonprofits
|
|
NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 25, 2027
|
— |
Nonprofits
|
|
Clinical and Translational Science Award (UM1 Clinical Trial Optional)
|
National Institutes of Health |
September 28, 2027
|
— |
Nonprofits
|
|
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
|
National Institutes of Health |
September 28, 2027
|
— |
|
|
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 28, 2027
|
— |
|
|
Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 28, 2027
|
— |
|
|
Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
|
National Institutes of Health |
September 29, 2027
|
$250k |
Nonprofits
|
|
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 4, 2027
|
— |
Nonprofits
|
|
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 8, 2027
|
— |
Nonprofits
|
|
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
|
National Institutes of Health |
October 8, 2027
|
— |
Nonprofits
|
|
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
|
National Institutes of Health |
October 12, 2027
|
$500k |
Nonprofits
|
|
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2027
|
— |
Nonprofits
|
|
NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)
|
National Institutes of Health |
October 14, 2027
|
— |
Nonprofits
|
|
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
October 15, 2027
|
— |
Nonprofits
|
|
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 16, 2027
|
— |
Nonprofits
|
|
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
|
National Institutes of Health |
October 18, 2027
|
— |
Nonprofits
|
|
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2027
|
$300k |
Nonprofits
|
|
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2027
|
$650k |
|
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 20, 2027
|
$750k |
Nonprofits
|
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 20, 2027
|
$750k |
Nonprofits
|
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 20, 2027
|
— |
Nonprofits
|
|
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
|
National Institutes of Health |
October 25, 2027
|
— |
Nonprofits
|